Cargando…

PB2424: ORAL VERSUS INTRAVENOUS ANTI-CMV PREEMPTIVE THERAPY IN ALLOGENEIC STEM CELL TRANSPLANT PATIENTS WITH CMV REACTIVATION: EXPERIENCE FROM NATIONAL CENTER OF BONE MARROW TRANSPLANTATION, TUNISIA.

Detalles Bibliográficos
Autores principales: Yosra Kanoun, Rimmel, Ben Adejlil, Nour, Rabeb, Jaied, Hsasna, Roua, Siwar, Frigui, Mekni, Sabrine, Torjemane, Lamia, Turki, Ines, Belloumi, Dorra, Rihab, Ouerghi, Yaiche, Insaf Ben, Wafa, Achour, Saloua, Ladeb, Ben Othman, Tarek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429059/
http://dx.doi.org/10.1097/01.HS9.0000976404.38888.d8
_version_ 1785090620477407232
author Yosra Kanoun, Rimmel
Ben Adejlil, Nour
Rabeb, Jaied
Hsasna, Roua
Siwar, Frigui
Mekni, Sabrine
Torjemane, Lamia
Turki, Ines
Belloumi, Dorra
Rihab, Ouerghi
Yaiche, Insaf Ben
Wafa, Achour
Saloua, Ladeb
Ben Othman, Tarek
author_facet Yosra Kanoun, Rimmel
Ben Adejlil, Nour
Rabeb, Jaied
Hsasna, Roua
Siwar, Frigui
Mekni, Sabrine
Torjemane, Lamia
Turki, Ines
Belloumi, Dorra
Rihab, Ouerghi
Yaiche, Insaf Ben
Wafa, Achour
Saloua, Ladeb
Ben Othman, Tarek
author_sort Yosra Kanoun, Rimmel
collection PubMed
description
format Online
Article
Text
id pubmed-10429059
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104290592023-08-17 PB2424: ORAL VERSUS INTRAVENOUS ANTI-CMV PREEMPTIVE THERAPY IN ALLOGENEIC STEM CELL TRANSPLANT PATIENTS WITH CMV REACTIVATION: EXPERIENCE FROM NATIONAL CENTER OF BONE MARROW TRANSPLANTATION, TUNISIA. Yosra Kanoun, Rimmel Ben Adejlil, Nour Rabeb, Jaied Hsasna, Roua Siwar, Frigui Mekni, Sabrine Torjemane, Lamia Turki, Ines Belloumi, Dorra Rihab, Ouerghi Yaiche, Insaf Ben Wafa, Achour Saloua, Ladeb Ben Othman, Tarek Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429059/ http://dx.doi.org/10.1097/01.HS9.0000976404.38888.d8 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Yosra Kanoun, Rimmel
Ben Adejlil, Nour
Rabeb, Jaied
Hsasna, Roua
Siwar, Frigui
Mekni, Sabrine
Torjemane, Lamia
Turki, Ines
Belloumi, Dorra
Rihab, Ouerghi
Yaiche, Insaf Ben
Wafa, Achour
Saloua, Ladeb
Ben Othman, Tarek
PB2424: ORAL VERSUS INTRAVENOUS ANTI-CMV PREEMPTIVE THERAPY IN ALLOGENEIC STEM CELL TRANSPLANT PATIENTS WITH CMV REACTIVATION: EXPERIENCE FROM NATIONAL CENTER OF BONE MARROW TRANSPLANTATION, TUNISIA.
title PB2424: ORAL VERSUS INTRAVENOUS ANTI-CMV PREEMPTIVE THERAPY IN ALLOGENEIC STEM CELL TRANSPLANT PATIENTS WITH CMV REACTIVATION: EXPERIENCE FROM NATIONAL CENTER OF BONE MARROW TRANSPLANTATION, TUNISIA.
title_full PB2424: ORAL VERSUS INTRAVENOUS ANTI-CMV PREEMPTIVE THERAPY IN ALLOGENEIC STEM CELL TRANSPLANT PATIENTS WITH CMV REACTIVATION: EXPERIENCE FROM NATIONAL CENTER OF BONE MARROW TRANSPLANTATION, TUNISIA.
title_fullStr PB2424: ORAL VERSUS INTRAVENOUS ANTI-CMV PREEMPTIVE THERAPY IN ALLOGENEIC STEM CELL TRANSPLANT PATIENTS WITH CMV REACTIVATION: EXPERIENCE FROM NATIONAL CENTER OF BONE MARROW TRANSPLANTATION, TUNISIA.
title_full_unstemmed PB2424: ORAL VERSUS INTRAVENOUS ANTI-CMV PREEMPTIVE THERAPY IN ALLOGENEIC STEM CELL TRANSPLANT PATIENTS WITH CMV REACTIVATION: EXPERIENCE FROM NATIONAL CENTER OF BONE MARROW TRANSPLANTATION, TUNISIA.
title_short PB2424: ORAL VERSUS INTRAVENOUS ANTI-CMV PREEMPTIVE THERAPY IN ALLOGENEIC STEM CELL TRANSPLANT PATIENTS WITH CMV REACTIVATION: EXPERIENCE FROM NATIONAL CENTER OF BONE MARROW TRANSPLANTATION, TUNISIA.
title_sort pb2424: oral versus intravenous anti-cmv preemptive therapy in allogeneic stem cell transplant patients with cmv reactivation: experience from national center of bone marrow transplantation, tunisia.
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429059/
http://dx.doi.org/10.1097/01.HS9.0000976404.38888.d8
work_keys_str_mv AT yosrakanounrimmel pb2424oralversusintravenousanticmvpreemptivetherapyinallogeneicstemcelltransplantpatientswithcmvreactivationexperiencefromnationalcenterofbonemarrowtransplantationtunisia
AT benadejlilnour pb2424oralversusintravenousanticmvpreemptivetherapyinallogeneicstemcelltransplantpatientswithcmvreactivationexperiencefromnationalcenterofbonemarrowtransplantationtunisia
AT rabebjaied pb2424oralversusintravenousanticmvpreemptivetherapyinallogeneicstemcelltransplantpatientswithcmvreactivationexperiencefromnationalcenterofbonemarrowtransplantationtunisia
AT hsasnaroua pb2424oralversusintravenousanticmvpreemptivetherapyinallogeneicstemcelltransplantpatientswithcmvreactivationexperiencefromnationalcenterofbonemarrowtransplantationtunisia
AT siwarfrigui pb2424oralversusintravenousanticmvpreemptivetherapyinallogeneicstemcelltransplantpatientswithcmvreactivationexperiencefromnationalcenterofbonemarrowtransplantationtunisia
AT meknisabrine pb2424oralversusintravenousanticmvpreemptivetherapyinallogeneicstemcelltransplantpatientswithcmvreactivationexperiencefromnationalcenterofbonemarrowtransplantationtunisia
AT torjemanelamia pb2424oralversusintravenousanticmvpreemptivetherapyinallogeneicstemcelltransplantpatientswithcmvreactivationexperiencefromnationalcenterofbonemarrowtransplantationtunisia
AT turkiines pb2424oralversusintravenousanticmvpreemptivetherapyinallogeneicstemcelltransplantpatientswithcmvreactivationexperiencefromnationalcenterofbonemarrowtransplantationtunisia
AT belloumidorra pb2424oralversusintravenousanticmvpreemptivetherapyinallogeneicstemcelltransplantpatientswithcmvreactivationexperiencefromnationalcenterofbonemarrowtransplantationtunisia
AT rihabouerghi pb2424oralversusintravenousanticmvpreemptivetherapyinallogeneicstemcelltransplantpatientswithcmvreactivationexperiencefromnationalcenterofbonemarrowtransplantationtunisia
AT yaicheinsafben pb2424oralversusintravenousanticmvpreemptivetherapyinallogeneicstemcelltransplantpatientswithcmvreactivationexperiencefromnationalcenterofbonemarrowtransplantationtunisia
AT wafaachour pb2424oralversusintravenousanticmvpreemptivetherapyinallogeneicstemcelltransplantpatientswithcmvreactivationexperiencefromnationalcenterofbonemarrowtransplantationtunisia
AT saloualadeb pb2424oralversusintravenousanticmvpreemptivetherapyinallogeneicstemcelltransplantpatientswithcmvreactivationexperiencefromnationalcenterofbonemarrowtransplantationtunisia
AT benothmantarek pb2424oralversusintravenousanticmvpreemptivetherapyinallogeneicstemcelltransplantpatientswithcmvreactivationexperiencefromnationalcenterofbonemarrowtransplantationtunisia